ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

Small But Valued NIH Grant Program Cut In FY92 Budget

April 12, 1991

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011